Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Michael O'Riordan

March 18, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

News Daily News

Polypills Added to List of WHO’s Essential Medicines

Michael O'Riordan

August 02, 2023

News Opinion CV Team Dispatch

May 2023 News Roundup

L.A. McKeown

May 01, 2023

News Daily News

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Michael O'Riordan

January 12, 2023

News Conference News AHA 2022

China Rural Intervention Still Reaping BP Control Wins at 3 Years

L.A. McKeown

November 09, 2022

News Daily News

Wearable Devices Are Cost-effective AF Screening Tools

Caitlin E. Cox

August 10, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Daily News

Women Less Likely Than Men to Experience SCD During Sports

Michael O'Riordan

December 21, 2021

News Conference News AHA 2021

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

Yael L. Maxwell

November 14, 2021

News Daily News

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Michael O'Riordan

October 28, 2021

News Daily News

Stroke Better Tackled by Mobile Interventional Teams Than by ‘Drip-and-Ship’

Yael L. Maxwell

August 05, 2021

News Conference News HRS 2021

Catheter Ablation ‘Good Value’ in CABANA Economic Analysis

Michael O'Riordan

August 04, 2021

News Daily News

Apple Heart in Print: The Conversation on Data Privacy Continues

Yael L. Maxwell

November 15, 2019

News Conference News SCCT 2019

Time to Ease Up on Prior Authorization for PCSK9 Inhibitors?

Yael L. Maxwell

July 15, 2019

News Conference News ACC 2019

Apple Watch May Detect A-fib in the General Population, but at What Cost?

Yael L. Maxwell

March 16, 2019

News Daily News

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Michael O'Riordan

October 25, 2018

News Daily News

Newly Defined Stage 1 Hypertension Tied to CVD Risk in Younger Chinese Adults

Todd Neale

September 07, 2018

News Daily News

Women Likely Not Good Targets for AAA Screening, Study Suggests

Lucy Hicks

August 13, 2018

Advertisement

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Statins Are Cost-effective in the Elderly

Polypills Added to List of WHO’s Essential Medicines

May 2023 News Roundup

CT Angiography Is Increasing in England, but Downstream Tests Are Not

China Rural Intervention Still Reaping BP Control Wins at 3 Years

Wearable Devices Are Cost-effective AF Screening Tools

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Women Less Likely Than Men to Experience SCD During Sports

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Stroke Better Tackled by Mobile Interventional Teams Than by ‘Drip-and-Ship’

Catheter Ablation ‘Good Value’ in CABANA Economic Analysis

Apple Heart in Print: The Conversation on Data Privacy Continues

Time to Ease Up on Prior Authorization for PCSK9 Inhibitors?

Apple Watch May Detect A-fib in the General Population, but at What Cost?

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Newly Defined Stage 1 Hypertension Tied to CVD Risk in Younger Chinese Adults

Women Likely Not Good Targets for AAA Screening, Study Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content